APO-ATENOL TAB 100MG 100 MG
ATENOLOL : 100 MG · DIN 00773697 · APOTEX INC
Health Canada status: MARKETED
What is APO-ATENOL TAB 100MG?
APO-ATENOL TAB 100MG 100 MG contains ATENOLOL : 100 MG. It is listed in the Health Canada Drug Product Database under DIN 00773697, held by APOTEX INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 31-Dec-1988. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is APO-ATENOL TAB 100MG used for?
APO-ATENOL (atenolol) is indicated for patients with mild or moderate hypertension and for the long-term management of patients with angina pectoris due to ischemic heart disease. It can be used alone or in combination with other drugs, particularly a thiazide diuretic, to treat hypertension.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 00773697 |
|---|---|
| Brand name | APO-ATENOL TAB 100MG |
| Generic / active ingredient | ATENOLOL : 100 MG |
| Manufacturer | APOTEX INC |
| Strength | 100 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | C07AB03 ATENOLOL |
| AHFS class | 24:24.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 31-Dec-1988 |
| Original market date | 1988-12-31 00:00:00 |
How is it stored and handled?
null
How is it supplied?
APO-ATENOL 50 mg - Available in bottles of 100 and 500, unit-dose packages of 30 and 100, and in Apotex Long-Term care Packages (Apo-LTC Packs) of 620 and 700 tablets. APO-ATENOL 100 mg - Available in bottles of 100 and 500, and in unit dose packages of 30 and 100 tablets.
Is ATENOLOL in shortage in Canada?
A Canadian shortage report is on file for this molecule: Anticipated — reported by SANIS HEALTH INC, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code C07AB03 ATENOLOL. 28 of 87 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-ATENOL TAB 50MG | 50 MG | TABLET | APOTEX INC | MARKETED | DIN 00773689 |
| ATENOLOL | 100 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02238318 |
| ATENOLOL | 100 MG | TABLET | PRO DOC LIMITEE | MARKETED | DIN 00828793 |
| ATENOLOL | 25 MG | TABLET | PRO DOC LIMITEE | MARKETED | DIN 02326701 |
| ATENOLOL | 25 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02541564 |
| ATENOLOL | 50 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02238316 |
| ATENOLOL | 50 MG | TABLET | PRO DOC LIMITEE | MARKETED | DIN 00828807 |
| JAMP-ATENOLOL | 100 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02367572 |
| JAMP-ATENOLOL | 25 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02367556 |
| JAMP-ATENOLOL | 50 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02367564 |
Who else supplies ATENOLOL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. ATENOLOL appears in 359 registered pack listings across 13 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.